Literature DB >> 2010242

Prognostic indicators of chronic chagasic cardiopathy.

R A Espinosa1, L R Pericchi, H A Carrasco, A Escalante, O Martínez, R González.   

Abstract

After 104 patients with positive serology for Chagas' disease had been followed for a decade, a selection of 66 patients was made from this number and a total of 25 variables obtained from clinical and paraclinical findings were analyzed, with the purpose of knowing which of these variables may be of help, in time, in determining prognosis. The information was analyzed using the Cox regression model. The patients were classified into groups according to the results in the invasive and noninvasive studies: those with a normal electrocardiogram without heart disease (14 patients) or with early segmental abnormalities of the left ventricle (9 patients); those with an abnormal electrocardiogram and advanced myocardial damage but without signs of congestive heart failure (26 patients); and those with an abnormal electrocardiogram together with congestive heart failure (17 patients). Of these patients, those with electrocardiographic abnormalities correspond to stages of the disease where advanced myocardial damage is proven. There was a 42% mortality during the follow-up of these patients. According to the regression model, the value of the systolic blood pressure is a good predictor of mortality (P = 0.0380) in those with congestive heart failure. When we analyzed jointly the patients with an abnormal electrocardiogram, we found that several variables (systolic blood pressure, the presence of atrial fibrillation, the radiologic cardiothoracic index, and left ventricular end-diastolic volume obtained by the ventriculogram), were negatively correlated with regard to survival. This last model has a chi-square of 11.36 (P = 0.0228). These models allow us to predict the prognosis in this group of patients with Chagas' disease and advanced myocardial damage.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1991        PMID: 2010242     DOI: 10.1016/0167-5273(91)90095-7

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  10 in total

1.  Value of echocardiography for diagnosis and prognosis of chronic Chagas disease cardiomyopathy without heart failure.

Authors:  R J Viotti; C Vigliano; S Laucella; B Lococo; M Petti; G Bertocchi; B Ruiz Vera; H Armenti
Journal:  Heart       Date:  2004-06       Impact factor: 5.994

Review 2.  Developments in the management of Chagas cardiomyopathy.

Authors:  Herbert B Tanowitz; Fabiana S Machado; David C Spray; Joel M Friedman; Oren S Weiss; Jose N Lora; Jyothi Nagajyothi; Diego N Moraes; Nisha Jain Garg; Maria Carmo P Nunes; Antonio Luiz P Ribeiro
Journal:  Expert Rev Cardiovasc Ther       Date:  2015-10-23

3.  Predictive factors for the progression of chronic Chagas cardiomyopathy in patients without left ventricular dysfunction.

Authors:  Silvana de Araújo Silva; Eliane Dias Gontijo; João Carlos Pinto Dias; Camila Gomes de Souza Andrade; Carlos Faria Santos Amaral
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015 Mar-Apr       Impact factor: 1.846

4.  ECG manifestations of the biggest outbreak of Chagas disease due to oral infection in Latin-America.

Authors:  Juan Marques; Iván Mendoza; Belkisyolé Noya; Harry Acquatella; Igor Palacios; María Marques-Mejias
Journal:  Arq Bras Cardiol       Date:  2013-07-26       Impact factor: 2.000

5.  Can Transthoracic Echocardiography Replace Chest Radiography in the Evaluation of Cardiomegaly in Chagas Cardiomyopathy?

Authors:  Tiago Senra
Journal:  Arq Bras Cardiol       Date:  2021-01       Impact factor: 2.000

6.  Biomarkers and mortality in severe Chagas cardiomyopathy.

Authors:  Jacqueline E Sherbuk; Emi E Okamoto; Morgan A Marks; Enzo Fortuny; Eva H Clark; Gerson Galdos-Cardenas; Angel Vasquez-Villar; Antonio B Fernandez; Thomas C Crawford; Rose Q Do; Jorge Luis Flores-Franco; Rony Colanzi; Robert H Gilman; Caryn Bern
Journal:  Glob Heart       Date:  2015-09

7.  Electrocardiographic abnormalities in Trypanosoma cruzi seropositive and seronegative former blood donors.

Authors:  Antonio L Ribeiro; Ester C Sabino; Milena S Marcolino; Vera M C Salemi; Barbara M Ianni; Fábio Fernandes; Luciano Nastari; André Antunes; Márcia Menezes; Cláudia Di Lorenzo Oliveira; Vandana Sachdev; Danielle M Carrick; Michael P Busch; Eduard L Murphy
Journal:  PLoS Negl Trop Dis       Date:  2013-02-28

8.  Electrocardiographic abnormalities in elderly Chagas disease patients: 10-year follow-up of the Bambui Cohort Study of Aging.

Authors:  Antonio Luiz P Ribeiro; Milena S Marcolino; Ronald J Prineas; Maria Fernanda Lima-Costa
Journal:  J Am Heart Assoc       Date:  2014-02-07       Impact factor: 5.501

Review 9.  Carlos Chagas Discoveries as a Drop Back to Scientific Construction of Chronic Chagas Heart Disease.

Authors:  Reinaldo B Bestetti; Carolina Baraldi A Restini; Lucélio B Couto
Journal:  Arq Bras Cardiol       Date:  2016-05-24       Impact factor: 2.000

10.  Risk Score for Predicting 2-Year Mortality in Patients With Chagas Cardiomyopathy From Endemic Areas: SaMi-Trop Cohort Study.

Authors:  Claudia Di Lorenzo Oliveira; Maria Carmo P Nunes; Enrico Antonio Colosimo; Emilly Malveira de Lima; Clareci S Cardoso; Ariela Mota Ferreira; Lea Campos de Oliveira; Carlos Henrique Valente Moreira; Ana Luiza Bierrenbach; Desireé Sant Ana Haikal; Sérgio Viana Peixoto; Maria Fernanda Lima-Costa; Ester Cerdeira Sabino; Antonio Luiz P Ribeiro
Journal:  J Am Heart Assoc       Date:  2020-03-11       Impact factor: 5.501

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.